MF
BCRX icon

Magnetar Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History

Magnetar Financial’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-116,020
Closed -$881K – 945
2025
Q3 		$881K Buy
116,020
+8,058
+7% +$67.1K 0.01% 485
2025
Q2 		$967K Buy
107,962
+82,542
+325% +$769K ﹤0.01% 446
2025
Q1 		$191K Buy
+25,420
New +$205K ﹤0.01% 677
2024
Q4 		– Sell
-17,928
Closed -$136K – 618
2024
Q3 		$136K Buy
+17,928
New +$136K ﹤0.01% 487

Other funds holding BCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return